Business
Placing to raise approximately £1.17 million
Placing to raise approximately £1.17 million.
About this update from Fusion Antibodies Plc
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.\n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED (\"EUWA\")) (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n18 March 2025\n \nFusion Antibodies plc\n(\"Fusion\" or the \"Company\")\n \nPlacing to raise approximately £1.17 million\n \nFusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it has conditionally raised approximately £1.17 million (before expenses) by way of a placing (the \"Placing\") of a total of 17,365,228 new ordinary shares of 4 pence each in the Company (\"Ordinary Shares\") at a price of 6.75 pence per new Ordinary Share (the \"Issue Price\").\n \nAllenby Capital Limited (\"Allenby Capital\") and Shard Capital Partners LLP (\"Shard\") are acting as the Company's joint brokers in connection with the Placing.\n \nKey highlights\n \n· Placing to raise approximately £1.17 million (before expenses) through the issue of 17,365,228 new Ordinary Shares (the \"Placing Shares\") at the Issue Price, of which approximately £0.57 million is conditional.\n \n· The Issue Price is equal to the closing mid-market price of an Ordinary Share on 17 March 2025.\n \n· The Placing will be conducted in two tranches a...